Abstract
Annonaceous acetogenins are potent cytotoxic agents against tumor cell lines as well as potent inhibitors of mitochondrial Complex I (Degli Esposti and Ghelli Biochim Biophys Acta 1187:116–120, 1994; Degli Esposti et al. Biochem J 301(Pt 1):161–167, 1994; Tormo et al. Arch Biochem Biophys 369:119–126, 1999). Eighteen different ACGs belonging to seven structural sub-families were tested against six tumor and two non tumor cell lines in a MTT cytotoxicity assay to evaluate the correlation between mitochondrial Complex I inhibition and cytotoxic activity potency and selectivity. The results showed a substantial heterogeneity in potency and selectivity among the different compounds tested, although no clear overall structure-activity relationships could be established. To further characterize the biological activity of these compounds, four ACGs were selected based on their inhibition binding sites to Complex I, to evaluate their cytotoxic activity over a 15-minute to 48-hour period using a more sensitive time-course LDH cytotoxicity assay. Our results indicate that, although all of the ACGs were highly cytotoxic in HepG2 cell lines at 24 h, each sub-class behaves rather differently at shorter times. Perhaps other aspects related to how these compounds reach or bind to their target sites, or differences in their ability to cross the cell and/or the mitochondrial membranes, could help explain their different activities. This different behavior between ACGs may provide new clues for a better understanding of their potential antitumor properties.
References
Alali FQ, Liu XX, McLaughlin JL (1999) Annonaceous acetogenins: recent progress. J Nat Prod 62:504–540
Barrachina I, Royo I, Baldoni HA, Chahboune N, Suvire F, DePedro N, Zafra-Polo MC, Bermejo A, El Aouad N, Cabedo N, Saez J, Tormo JR, Enriz RD, Cortes D (2007) New antitumoral acetogenin ‘Guanacone type’ derivatives: isolation and bioactivity. Molecular dynamics simulation of diacetyl-guanacone. Bioorg Med Chem 15:4369–4381
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306
Chahboune N, Barrachina I, Royo I, Romero V, Saez J, Tormo JR, De Pedro N, Estornell E, Zafra-Polo MC, Pelaez F, Cortes D (2006) Guanaconetins, new antitumoral acetogenins, mitochondrial complex I and tumor cell growth inhibitors. Bioorg Med Chem 14:1089–1094
Corine V, Coiffard C, Coifard LJM, Rivalland P, De Roeck-Holtzhauer Y (1998) In vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium laurylsulfate cytotoxicity. J Pharmacol Toxicol 39:143–146
Cragg GM (2002) Natural product drug discovery and development: the United States National Cancer Institute role. P R Health Sci J 21:97–111
Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100:72–79
Cragg GM, Grothaus PG, Newman DJ (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043
Degli Esposti M, Ghelli A (1994) The mechanism of proton and electron transport in mitochondrial complex I. Biochim Biophys Acta 1187:116–120
Degli Esposti M, Ghelli A, Ratta M, Cortes D, Estornell E (1994) Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). Biochem J 301(Pt 1):161–167
Escobar-Khondiker M, Hollerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, Yamada ES, Lannuzel A, Yagi T, Hirsch EC, Oertel WH, Jacob R, Michel PP, Ruberg M, Hoglinger GU (2007) Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci 27:7827–7837
Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Liu Y, Nair MG (2010) An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds. J Nat Prod 73:1193–1195
Lopez-Lazaro M, Martin-Cordero C, Bermejo A, Cortes D, Ayuso MJ (2001) Cytotoxic compounds from Annonaceus species as DNA topoisomerase I poisons. Anticancer Res 21:3493–3497
Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, March 6, 2009
McLaughlin JL (2008) Paw paw and cancer: annonaceous acetogenins from discovery to commercial products. J Nat Prod 71:1311–1321
Royo I, DePedro N, Estornell E, Cortes D, Pelaez F, Tormo JR (2003) In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: correlations with their inhibition of mitochondrial Complex I. Oncol Res 13:521–528
Ruch RJ, Crist KA, Klaunig JE (1989) Effects of culture duration on hydrogen peroxide-induced hepatocyte toxicity. Toxicol Appl Pharmacol 100:451–464
Schlie-Guzman MA, Gonzalez-Esquinca AR, Luna-Cazares LM (2009) Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 8(4):245–257. BLACPMA ISSN 0717 7917
Schlie-Guzman MA, Garcia-Carranca A, Gonzalez-Esquinca AR (2009b) In vitro and in vivo antiproliferative activity of laherradurin and cherimolin-2 of Annona diversifolia Saff. Phytother Res 23:1128–1133
Tormo JR, Estornell E (2000) New evidence for the multiplicity of ubiquinone- and inhibitor-binding sites in the mitochondrial complex I. Arch Biochem Biophys 381:241–246
Tormo JR, Gonzalez MC, Cortes D, Estornell E (1999) Kinetic characterization of mitochondrial complex I inhibitors using annonaceous acetogenins. Arch Biochem Biophys 369:119–126
Tormo JR, Royo I, Gallardo T, Zafra-Polo MC, Hernandez P, Cortes D, Pelaez F (2003) In vitro antitumor structure-activity relationships of threo/trans/threo mono-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I. Oncol Res 14:147–154
Tormo JR, DePedro N, Royo I, Barrachina I, Zafra-Polo MC, Cuadrillero C, Hernandez P, Cortes D, Pelaez F (2005) In vitro antitumor structure-activity relationships of threo/trans/threo/trans/erythro bis-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I. Oncol Res 15:129–138
Yang H, Zhang N, Li X, Chen J, Cai B (2009) Structure-activity relationships of diverse annonaceous acetogenins against human tumor cells. Bioorg Med Chem Lett 19:2199–2202
Yuan SS, Chang HL, Chen HW, Yeh YT, Kao YH, Lin KH, Wu YC, Su JH (2003) Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway. Life Sci 72:2853–2861
Zafra-Polo MC, Gonzalez MC, Estornell E, Sahpaz S, Cortes D (1996) Acetogenins from Annonaceae, inhibitors of mitochondrial complex I. Phytochemistry 42:253–271
Zhu XF, Liu ZC, Xie BF, Li ZM, Feng GK, Xie HH, Wu SJ, Yang RZ, Wei XY, Zeng YX (2002) Involvement of caspase-3 activation in squamocin-induced apoptosis in leukemia cell line HL-60. Life Sci 70:1259–1269
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Pedro, N., Cautain, B., Melguizo, A. et al. Analysis of cytotoxic activity at short incubation times reveals profound differences among Annonaceus acetogenins, inhibitors of mitochondrial Complex I. J Bioenerg Biomembr 45, 145–152 (2013). https://doi.org/10.1007/s10863-012-9490-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-012-9490-8